The landscape of dementia analysis has advanced substantially with the advent of refined biomarkers, such as amyloid PET scans, tau imaging, and blood-centered assessments that will detect Alzheimer's pathology years right before indicators emerge. When these technological improvements represent amazing progress in being familiar with neurodegenerative conditions, they have not https://paulc197akt5.empirewiki.com/user